header-logo
GettyImages-609179959-hero
Endocrinology and Molecular Medicine

Sahoo Laboratory

Location
Health Research Center
H4930

General Interests
Lipoprotein Metabolism, Scavenger Receptors, Cardiovascular Disease, Diabetes, Obesity

View Daisy Sahoo, PhD Bio
Daisy Sahoo Laboratory

Research Areas

The role of scavenger receptors in cardiovascular disease and related metabolic disorders.

Atherosclerosis is a disease caused by plaque build-up in the artery wall, which ultimately results in reduced blood flow due to narrowing of the arteries. Plaque build-up results from the accumulation of cholesterol and other cellular debris. Cholesterol is carried through our bloodstream in vehicles called lipoproteins. Low density lipoproteins (LDL) – the “bad cholesterol” – carry cholesterol from the liver to peripheral tissues (such as the arterial wall). High density lipoproteins (HDL) – the “good cholesterol” – transport cholesterol from peripheral tissues back to the liver for excretion in a process called “reverse cholesterol transport.”

While HDL protects against atherosclerosis due to its role in reducing oxidative damage, preventing inflammation and promoting endothelial function, our lab is very interested in the role that HDL plays in reverse cholesterol transport and whole body cholesterol disposal.

Scavenger receptor class B type I (SR-BI), the most physiologically relevant HDL receptor, is highly expressed in the liver and plays a key role in mediating the delivery of HDL-C to the liver for excretion. Genetic mouse models demonstrate that SR-BI protects against atherosclerosis. Further, the recent discovery of SR-BI mutations in patients with high HDL-C levels strongly supports a critical role of SR-BI in facilitating the flux of cholesterol out of the body.

In order to develop novel therapeutic strategies that treat hypercholesterolemia and its associated pathologies such as atherosclerosis, it is critical that we understand the mechanisms that regulate receptor-ligand interactions at the end of reverse cholesterol transport. A better understanding of the interaction between SR-BI and HDL will allow us to gain novel insight into mechanisms that facilitate the efficient clearance of HDL-C via SR-BI-mediated selective uptake of HDL lipids.

Our laboratory is trying to answer the following questions:

  • What are key structural features of SR-BI that facilitate HDL-cholesterol transport?
  • Can we use biophysical and high-resolution techniques to gain structural information about full-length SR-BI and/or its extracellular/transmembrane domains?
  • What is the oligomeric organization of SR-BI and how does that influence HDL-cholesterol transport?
  • How does oxidation of HDL impact its cardio-protective functions and the progression of atherosclerosis?
  • How does SR-BI facilitate cholesterol delivery into adipocytes?
  • What happens when HDL-cholesterol gets hydrolyzed in cells?
  • How does HDL impact beta cell function and diabetes?

Techniques

Research in the Sahoo laboratory relies on several techniques that will teach the following:

  • Cell culture-based cholesterol transport assays
  • Lipid and lipoprotein analyses
  • Signal transduction
  • Protein-protein interactions using biophysical/biochemical methods
  • Fluorescence methodologies (e.g. spin labeling, FRET)
  • Live cell imaging
  • Confocal microscopy
  • Mass Spectrometry (via collaboration)
  • NMR (via collaboration)
  • EPR (via collaboration)
  • In vivo mouse models that express SR-BI mutants
  • In vivo reverse cholesterol transport and atherosclerosis studies

Current Members

headshot

Jordan Bobek

Graduate Student

jbobek@mcw.edu

headshot

Renee Penoske

Research Associate II

rpenoske@mcw.edu

headshot

Gage Stuttgen

Graduate Student

gstuttgen@mcw.edu

headshot

Emma Tillison

G3 Student

etillison@mcw.edu

headshot

Guadalupe Valdivia Esparza

G2 Student

gvaldivia@mcw.edu

Scenes from the Sahoo Laboratory

1 /
Member of Sahoo Laboratory
Hide Caption
Research being done in Sahoo Laboratory
Hide Caption
Work in the Sahoo Laboratory
Hide Caption
Members collaborating on research in the Sahoo Laboratory
Hide Caption

Alumni/Former Trainees

  • Gabriella Papale, PhD (2008-2012)
  • Alexandra Chadwick, PhD (2010-2015)
  • Rebecca Schill, PhD (2012-2018)
  • Darcy Knaack
  • Hayley Powers

Recent Publications

Publications of Daisy Sahoo PhD from the Faculty Collaboration Database

© 2025 Medical College of Wisconsin.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The Medical College of Wisconsin (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. MCW maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

MCW's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.